FDA publishes SOP on pharma cargo thefts
Phil Taylor, 04-Apr-2012
The US Food and Drug Administration
has published a standard operating procedure (SOP) for determining
its response to cargo thefts, saying it is "very concerned" about
the problem.
Although recent figures suggest that pharmaceutical thefts actually
declined in
the US in 2011, the FDA said it is important to have consistent
procedures for "product removal from the market, public notice, and
handling medical product shortages".
Moreover, the
new document also makes pharma companies' responsibilities
absolutely clear, noting that drugmakers have a duty to report
pertinent information about a theft, including the type, amount and
dosage form of product taken, storage and handling requirements,
how much of the material has legitimately entered the supply chain,
tampering protections and the risks posed by the product if
mishandled.
Companies will also have to advise of the potential for the product
to re-enter the legitimate supply chain, and any mitigating factors
taken to identify stolen material and prevent re-entry. If a firm's
response is considered inadequate the FDA reserves the right to
issue its own notification to the public.
There were 36 incidents involving pharmaceutical shipments last
year in the US, down from 49 in 2010, while the average value of
lost shipments shrank from $3.78m to $585,000.
©
SecuringIndustry.com